A drug product combines pharmacologic activity with pharmaceutical properties. Desirable
performance characteristics are physical and chemical stability, ease of processing …

Development of dry powder aerosol drug delivery system includes powder production,
formulation, dispersion, and delivery of the powder aerosol to the lung. Conventional …

This article is the second part of a review on the nanoscale in pulmonary drug delivery.
Specifically it summarises and analyses the potential of the different inhalation delivery …

Drug administration by inhalation is a well-established approach to treat respiratory and
systemic diseases. To deliver a drug into the lung dry powder inhalation (DPI) is an …

Pulmonary route is extensively studied for the diagnosis and treatment of pulmonary and
extra pulmonary disease conditions such as asthma, tuberculosis, emphysema, and …

Delivery of drugs to the lungs via dry powder inhaler (DPI) is a promising approach for the
treatment of both local pulmonary conditions and systemic diseases. Though DPIs are …

Novel inhaled therapeutics including antibiotics, vaccines and anti-hypertensives, have led
to innovations in designing suitable delivery systems. These emerging design technologies …

Pulmonary drug delivery can have several advantages over other administration routes, in
particular when using dry powder formulations. Such dry powder inhalation formulations …

Targeted delivery of chemotherapeutics through the respiratory system is a potential
approach to improve drug accumulation in the lung tumor, while decreasing their negative …

Introduction: The number of pulmonary diseases that are effectively treated by aerosolized
medicine continues to grow. Areas covered: These diseases include chronic obstructive …